Home > Browse Research > Life Sciences > Pharmaceuticals > Drug Discovery

Drug Discovery: market research reports

Drug Discovery market research reports and industry analysis

Post Menopausal Osteoporosis – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... therapeutic development for Post Menopausal Osteoporosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post Menopausal Osteoporosis. Post Menopausal Osteoporosis ... \| read more...	$2,000.00
H3N2 Infection – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... for H3N2 Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H3N2 Infection. H3N2 Infection - Pipeline Review, Half Year ... \| read more...	$2,000.00
Sarcopenia – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sarcopenia. Sarcopenia - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Septic Shock – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... for Septic Shock, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Septic Shock. Septic Shock - Pipeline Review, Half Year ... \| read more...	$2,000.00
Interstitial Cystitis (Painful Bladder Syndrome) – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... provides information on the therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for ... \| read more...	$2,000.00
Cutaneous T-Cell Lymphoma – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... therapeutic development for Cutaneous T-Cell Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cutaneous T-Cell Lymphoma. Cutaneous T-Cell Lymphoma ... \| read more...	$2,000.00
Burns – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Burns. Burns - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Myelofibrosis – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Myelofibrosis. Myelofibrosis - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Osteosarcoma – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Osteosarcoma. Osteosarcoma - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... on the therapeutic development for Post-Traumatic Stress Disorder (PTSD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post-Traumatic Stress Disorder ... \| read more...	$2,000.00
Choroidal Neovascularization – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... for Choroidal Neovascularization, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Choroidal Neovascularization. Choroidal Neovascularization - Pipeline Review, Half Year ... \| read more...	$2,000.00
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... This report provides information on the therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ... \| read more...	$2,000.00
Diphtheria – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diphtheria. Diphtheria - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Metastatic Lung Cancer – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... therapeutic development for Metastatic Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Lung Cancer. Metastatic Lung Cancer ... \| read more...	$2,000.00
Rabies – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rabies. Rabies - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Pruritus – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pruritus. Pruritus - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
B-Cell Chronic Lymphocytic Leukemia – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... on the therapeutic development for B-Cell Chronic Lymphocytic Leukemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for B-Cell Chronic Lymphocytic ... \| read more...	$2,000.00
Bronchopulmonary Dysplasia – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... for Bronchopulmonary Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchopulmonary Dysplasia. Bronchopulmonary Dysplasia - Pipeline Review, Half Year ... \| read more...	$2,000.00
Friedreich Ataxia – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... for Friedreich Ataxia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Friedreich Ataxia. Friedreich Ataxia - Pipeline Review, Half Year ... \| read more...	$2,000.00
Secondary Hyperparathyroidism – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... for Secondary Hyperparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Secondary Hyperparathyroidism. Secondary Hyperparathyroidism - Pipeline Review, Half Year ... \| read more...	$2,000.00
Burkitt Lymphoma – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... for Burkitt Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Burkitt Lymphoma. Burkitt Lymphoma - Pipeline Review, Half Year ... \| read more...	$2,000.00
Percutaneous Coronary Intervention – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... therapeutic development for Percutaneous Coronary Intervention, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Percutaneous Coronary Intervention. Percutaneous Coronary Intervention ... \| read more...	$2,000.00
Athlete's Foot (Tinea Pedis) – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... on the therapeutic development for Athlete's Foot (Tinea Pedis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Athlete's Foot (Tinea ... \| read more...	$2,000.00
Cardiomyopathy – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiomyopathy. Cardiomyopathy - Pipeline Review, Half Year is built using data and ... \| read more...	$2,000.00
Chagas Disease (American Trypanosomiasis) – Pipeline Review, H1 2013 4/17/2013 \| published by: Global Markets Direct ... on the therapeutic development for Chagas Disease (American Trypanosomiasis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chagas Disease (American ... \| read more...	$2,000.00

< prev 4 5 6 7 8 9 10 11 12 13 next >